Entering the second decade: FEBS Open Bio in 2022

FEBS Open Bio continues to go from strength to strength, with 2021 perhaps marking its most exciting year. In this Editorial, the Editor‐in‐Chief Miguel A. De la Rosa looks back at all the new developments of 2021 and forecasts the outlook for 2022.

Detalles Bibliográficos
Autores principales: Wright, Duncan E., De la Rosa, Miguel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727927/
https://www.ncbi.nlm.nih.gov/pubmed/34927398
http://dx.doi.org/10.1002/2211-5463.13343
Descripción
Sumario:FEBS Open Bio continues to go from strength to strength, with 2021 perhaps marking its most exciting year. In this Editorial, the Editor‐in‐Chief Miguel A. De la Rosa looks back at all the new developments of 2021 and forecasts the outlook for 2022.

Ejemplares similares